Economic evaluation of home medication review by community pharmacists (HMR-CP) for patients with type 2 diabetes mellitus (T2DM)

Objective: Home medication review (HMR) programs could minimise patients’ health-related costs and burdens, thereby enhancing the quality of life and well-being. The aim of this economic evaluation is to determine if home medication review by community pharmacists (HMR-CP) for patients with type 2 d...

Full description

Bibliographic Details
Main Authors:	Karuppannan, M. (Author), Neoh, C.F (Author), Rosli, M.R (Author), Wu, D.B.-C (Author)
Format:	Article
Language:	English
Published:	Taylor and Francis Ltd. 2021
Series:	Journal of Medical Economics
Subjects:	adult aged Article clinical effectiveness community pharmacist comparative study controlled study cost benefit analysis cost effectiveness analysis cost utility analysis Cost-Benefit Analysis Cost-utility diabetes Diabetes Mellitus, Type 2 drug cost drug use economic evaluation female follow up health care access health care cost health care personnel health program health service hemoglobin A1c home care home medication review human Humans lifespan major clinical study Malaysian male Markov chain non insulin dependent diabetes mellitus outcome assessment pharmacist Pharmacists pharmacy pharmacy (shop) quality adjusted life year quality of life Quality of Life Quality-Adjusted Life Years randomized controlled trial risk factor
Online Access:	View Fulltext in Publisher View in Scopus

Internet

View Fulltext in Publisher
View in Scopus

Economic evaluation of home medication review by community pharmacists (HMR-CP) for patients with type 2 diabetes mellitus (T2DM)

Internet

Similar Items